Studies have shown that albumin nanoparticles loaded with bevacizumab can selectively accumulate in tumor blood vessels, effectively inhibit tumor angiogenesis, improve tumor vascular function, and enhance the oxygenation status of tumor tissues. This evidence concerns the gene ALB and neoplasm.